The Effect of Obesity on Short- and Long-Term Outcome after Surgical Treatment for Acute Type A Aortic Dissection.
aortic dissection
aortic surgery
long-term survival
obesity
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
30 Jul 2024
30 Jul 2024
Historique:
received:
31
05
2024
revised:
24
07
2024
accepted:
28
07
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
A paradox of lower morbidity and mortality in overweight or obese patients undergoing cardiac surgery has been described; however, knowledge about the influence of obesity in patients with acute Type A aortic dissection (AAD) is limited. This study aimed to evaluate the effect of obesity on short- and long-term outcomes after surgical treatment for AAD. Between 01/2004 and 12/2022, 912 patients with a BMI of 18.5 or greater were operated on for AAD. Patients were grouped according to their BMI (normal weight: BMI 18.5-24.9, Obese patients were younger at the time of AAD ( There are no indications that the obesity paradox is applicable in the setting of AAD. Since obese patients are affected by AAD at a younger age, obesity might constitute a risk factor for AAD. However, obesity does not influence short- or long-term survival. Regardless of body weight, immediate surgical therapy remains the treatment of choice for AAD.
Sections du résumé
BACKGROUND
BACKGROUND
A paradox of lower morbidity and mortality in overweight or obese patients undergoing cardiac surgery has been described; however, knowledge about the influence of obesity in patients with acute Type A aortic dissection (AAD) is limited. This study aimed to evaluate the effect of obesity on short- and long-term outcomes after surgical treatment for AAD.
METHODS
METHODS
Between 01/2004 and 12/2022, 912 patients with a BMI of 18.5 or greater were operated on for AAD. Patients were grouped according to their BMI (normal weight: BMI 18.5-24.9,
RESULTS
RESULTS
Obese patients were younger at the time of AAD (
CONCLUSIONS
CONCLUSIONS
There are no indications that the obesity paradox is applicable in the setting of AAD. Since obese patients are affected by AAD at a younger age, obesity might constitute a risk factor for AAD. However, obesity does not influence short- or long-term survival. Regardless of body weight, immediate surgical therapy remains the treatment of choice for AAD.
Identifiants
pubmed: 39202697
pii: life14080955
doi: 10.3390/life14080955
pmc: PMC11355667
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Cardiovasc Surg (Torino). 2017 Feb;58(1):113-120
pubmed: 26939045
Chest. 2000 May;117(5):1271-8
pubmed: 10807810
Ann Transl Med. 2021 Sep;9(18):1442
pubmed: 34733994
Circulation. 2017 Feb 28;135(9):850-863
pubmed: 28034901
Eur J Cardiothorac Surg. 2011 Nov;40(5):1078-84
pubmed: 21570858
Clin Lab. 2013;59(1-2):155-61
pubmed: 23505921
Ann Thorac Surg. 2018 Aug;106(2):491-497
pubmed: 29673638
Rev Esp Cardiol. 2011 Feb;64(2):140-9
pubmed: 21277668
Am Heart J. 2008 Jul;156(1):13-22
pubmed: 18585492
Surgeon. 2013 Jun;11(3):169-76
pubmed: 23490287
Lancet. 2021 Sep 11;398(10304):957-980
pubmed: 34450083
Eur J Cardiothorac Surg. 2011 Apr;39(4):519-22
pubmed: 20615719
Circulation. 2018 Mar 27;137(13):1391-1406
pubmed: 29581366
Medicina (Kaunas). 2024 Mar 07;60(3):
pubmed: 38541169
Mayo Clin Proc. 2004 Feb;79(2):176-80
pubmed: 14959911
Swiss Med Wkly. 2017 Sep 05;147:w14489
pubmed: 28871571
COPD. 2017 Dec;14(6):663-673
pubmed: 29210599
Nat Clin Pract Cardiovasc Med. 2009 Feb;6(2):140-6
pubmed: 19065126
Ann Cardiothorac Surg. 2016 Jul;5(4):368-76
pubmed: 27563550
Lancet. 2024 Mar 16;403(10431):1027-1050
pubmed: 38432237
J Cardiometab Syndr. 2008 Summer;3(3):155-61
pubmed: 18983332
Appl Physiol Nutr Metab. 2008 Oct;33(5):997-1006
pubmed: 18923576
J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1911-1921
pubmed: 29358013
Physiol Rev. 2008 Apr;88(2):389-419
pubmed: 18391168
J Cardiol. 2016 Sep;68(3):215-21
pubmed: 26526640
Am J Cardiol. 2012 Nov 6;110(9 Suppl):4B-12B
pubmed: 23062567
BMC Cardiovasc Disord. 2022 Aug 1;22(1):346
pubmed: 35915399
Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):981-988
pubmed: 30715366
Am J Cardiol. 2014 Feb 15;113(4):724-30
pubmed: 24484863
J Cardiothorac Vasc Anesth. 2020 Apr;34(4):867-873
pubmed: 31558394
Circulation. 2018 Apr 24;137(17):1846-1860
pubmed: 29685932
Ann Thorac Surg. 2011 Oct;92(4):1376-82
pubmed: 21855849
Circ Rep. 2020 Oct 23;2(11):639-647
pubmed: 33693190
Future Cardiol. 2010 Jan;6(1):1-6
pubmed: 20014982
Front Cardiovasc Med. 2022 Jul 12;9:899050
pubmed: 35903673
Interact Cardiovasc Thorac Surg. 2017 Oct 1;25(4):633-642
pubmed: 28962502
Ann Thorac Surg. 2018 Jan;105(1):137-143
pubmed: 29054307
Eur J Cardiothorac Surg. 2024 Feb 1;65(2):
pubmed: 38408364
J Thorac Cardiovasc Surg. 2014 Dec;148(6):2995-3000
pubmed: 25433882
J Cardiothorac Surg. 2021 Apr 23;16(1):107
pubmed: 33892753
J Cardiothorac Surg. 2021 Dec 28;16(1):359
pubmed: 34963491
BMC Cardiovasc Disord. 2023 Oct 31;23(1):531
pubmed: 37907847
Clin Physiol Funct Imaging. 2020 Sep;40(5):360-368
pubmed: 32544296
J Am Coll Cardiol. 2009 May 26;53(21):1925-32
pubmed: 19460605
J Diabetes Res. 2018 Nov 4;2018:3407306
pubmed: 30525052
J Thorac Cardiovasc Surg. 2018 Sep;156(3):939-948
pubmed: 29753501
Eur J Cardiothorac Surg. 2020 Oct 1;58(4):700-706
pubmed: 32492120
J Cardiothorac Surg. 2021 Jun 22;16(1):179
pubmed: 34158094
Tex Heart Inst J. 2019 Feb 1;46(1):7-13
pubmed: 30833831
Cardiol Clin. 2017 Aug;35(3):331-345
pubmed: 28683905